These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study. Germán-Díaz M, Alcolea A, Cabello V, Blasco-Alonso J, Rodríguez A, Galera R, García-Romero R, Romero C, González-Sacristán R, Redecillas-Ferreiro S, Moreno-Villares JM, Ramos-Boluda E. Eur J Pediatr; 2024 Aug; 183(8):3173-3182. PubMed ID: 38664251 [Abstract] [Full Text] [Related]
8. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure. Jeppesen PB, Gabe SM, Seidner DL, Lee HM, Olivier C. Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926 [Abstract] [Full Text] [Related]
9. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure. Chen K, Mu F, Xie J, Kelkar SS, Olivier C, Signorovitch J, Jeppesen PB. JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876 [Abstract] [Full Text] [Related]
11. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure. Kochar B, Long MD, Shelton E, Young L, Farraye FA, Yajnik V, Herfarth H. J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811 [Abstract] [Full Text] [Related]
12. Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure. Wales PW, Hill S, Robinson I, Raphael BP, Matthews C, Cohran V, Carter B, Venick R, Kocoshis S. J Pediatr Gastroenterol Nutr; 2024 Aug; 79(2):290-300. PubMed ID: 38873891 [Abstract] [Full Text] [Related]
16. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure. Pironi L, Allard JP, Joly F, Geransar P, Genestin E, Pape UF. Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295 [Abstract] [Full Text] [Related]
17. Changes in Parenteral Nutrition Requirements and BMI in Patients with Parenteral Nutrition-Dependent Short Bowel Syndrome after Stopping Teduglutide-9 Years of Follow-Up. Zaczek Z, Jurczak-Kobus P, Panczyk M, Braszczyńska-Sochacka J, Majewska K, Kunecki M, Dąbrowska K, Sobocki J. Nutrients; 2022 Apr 14; 14(8):. PubMed ID: 35458196 [Abstract] [Full Text] [Related]
19. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis. Micic D, Robinson I, Kidd T, Terreri B, Raphael BP. Nutr Clin Pract; 2024 Jun 14; 39(3):634-640. PubMed ID: 38491966 [Abstract] [Full Text] [Related]
20. Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome-associated intestinal failure. Seidner DL, Schwartz LK, Winkler MF, Jeejeebhoy K, Boullata JI, Tappenden KA. JPEN J Parenter Enteral Nutr; 2013 Mar 14; 37(2):201-11. PubMed ID: 23343999 [Abstract] [Full Text] [Related] Page: [Next] [New Search]